This session will review the newest ATS guidelines for latent TB infection diagnosis and management. This session will also describe the available TB immunodiagnostics and the science behind new developing technologies for the immunodiagnostics of the spectrum of TB infections. The session will also provide a perspective of how best to apply available technologies.